World Lupus Federation

05/15/2026

Thank you to Boehringer Ingelheim for supporting !

Their support helped make possible the latest global lupus awareness survey findings and white paper, highlighting the ongoing need for lupus awareness and education worldwide.

05/12/2026

The World Lupus Federation has released a white paper exploring global awareness, attitudes, and misconceptions about lupus, highlighting the ongoing need for greater education, visibility, and support for people living with lupus worldwide.

Read more: https://worldlupusfederation.org/2026/05/11/understanding-lupus-public-awareness-and-attitudes-ahead-of-world-lupus-day-2026/

05/10/2026

Today is — when we all take a moment to show support for the millions affected by lupus. It’s easy to raise lupus awareness! Wear purple and share lupus facts from our toolkit at WorldLupusDay.org/tool-kit

05/09/2026

Just one day to go until ! Get ready to raise your voice and help around the world.
Visit the awareness toolkit and join us in spreading the word: https://worldlupusday.org/tool-kit/

05/07/2026

New global survey results from the World Lupus Federation show that 58% of people worldwide still know little or nothing about lupus — and misconceptions about the disease remain common.
As approaches on May 10, help us raise awareness, share facts, and Make Lupus Visible for the millions impacted worldwide. Read the full findings: https://worldlupusfederation.org/2026/05/05/new-world-lupus-federation-global-survey-finds-58-know-very-little-or-nothing-about-lupus/

05/01/2026

Lupus Awareness Month starts today! Get ready to support millions impacted by lupus on , May 10! Wear purple, share facts, and more. Learn more ways to get involved on World Lupus Day: https://worldlupusfederation.org/2026/04/28/join-the-global-lupus-community-on-world-lupus-day-to-make-lupus-visible/

01/23/2026

Institute for Health and Care Excellence has approved a twice-yearly infusion of obinutuzumab (Gazyvaro), taken with a daily immunosuppressant tablet, mycophenolate mofetil, for people with severe lupus nephritis.

Learn more:

HomeNewsNews articlesThousands living with lupus offered hope from twice-yearly infusionNICE approves breakthrough combination treatment that restores normal kidney function in almost half of patients with lupus nephritis.News22 January 2026The treatment has been approved for NHS use, offering new h...

12/10/2025

The European Commission has approved Roche’s Gazyva/Gazyvaro for adults with active lupus nephritis, expanding treatment options across the EU. The decision follows strong trial results showing better kidney outcomes than standard therapy alone.
Read more:

Approval based on phase II NOBILITY and phase III REGENCY studies showing superiority of Gazyva/Gazyvaro over standard therapy alone1,2Gazyva/Gazyvaro is the only anti-CD20 antibody to demonstrate ...

11/25/2025

A decade of collaboration has helped the World Lupus Federation grow from 100 to more than 200 member organizations, creating a unified voice advancing lupus awareness, improving care, and accelerating research worldwide. Read more about the Federation’s impact: https://worldlupusfederation.org/2025/01/27/celebrating-a-decade-of-impact-10-accomplishments-of-the-world-lupus-federation/

05/12/2025